DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Terpos E, Heath DJ, Rahemtulla A. et al.
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
Br J Haematol 2006; 135 (5): 688-692
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.